Legal Opinion
Rafferty v. Merck & Co., Inc.
Massachusetts Supreme Judicial Court
Decided March 16, 2018No. SJC 12347PublishedCited by 53 opinions
1Opinion of the CourtGants, C.J.
*1209 **142 Under Federal law, a manufacturer of a generic drug must provide its users with a warning label that is identical to the label of the brand-name counterpart. See PLIVA, Inc . v. Mensing , 564 U.S. 604 , 613, 131 S.Ct. 2567 , 180 L.Ed.2d 580 (2011) ( PLIVA ). The issue on appeal is whether a plaintiff who alleges that he was injured from his use of a generic drug, because of a failure to warn of the drug's side effects, may bring a common-law general negligence claim and a statutory claim under G. L. c. 93A against the brand-name drug manufacturer that created the warning label.…
2Cases cited55 opinions
- New York Times Co. v. SullivanSupreme Court of the United States · 1964
- Wyeth v. LevineSupreme Court of the United States · 2009
- PLIVA, Inc. v. MensingSupreme Court of the United States · 2011
- Escola v. Coca Cola Bottling Co.California Supreme Court · 1944
- Payton v. Abbott LabsMassachusetts Supreme Judicial Court · 1982
50 more not listed; retrieve them via the Exa API.
3Cited by53 opinions
- McNair v. Johnson & JohnsonWest Virginia Supreme Court · 2018
- Ipsen v. Diamond Tree ExpertsUtah Supreme Court · 2020
- N.E. Bridge Contractors, Inc. v. Aspen Aerials, Inc.District Court, District of Columbia · 2019
- 694 Worcester St LLC and Others v. Ccp Counter Manor 0507 LLC and OthersMassachusetts Superior Court · 2025
- Anywherecommerce, Inc. v. Ingenico, Inc.District Court, D. Massachusetts · 2023
48 more not listed; retrieve them via the Exa API.